市場調査レポート
商品コード
1140676
テレメトリー式ECG装置の世界市場-2022-2029Global ECG Telemetry Devices Market - 2022-2029 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
テレメトリー式ECG装置の世界市場-2022-2029 |
出版日: 2022年10月20日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
|
家庭用モニタリング機器が市場の成長をリードします。
ホームケアモニタリングデバイスの需要が増加し、病院での心臓検査にかかる費用と時間が削減されます。心血管障害などの生命を脅かす疾患では、心臓の定期的なチェックが重要ですが、ホームケアモニタリングデバイスを使用することでそれが容易になります。そのため、これらの機器はテレメトリー式ECG装置市場の成長に貢献しています。
また、心血管疾患の発生率と有病率の増加が市場成長の原動力となっています。過去20年間、心血管疾患やその他の心臓疾患による死亡者数は高所得国では減少していますが、低所得国や中所得国では驚くほどの割合で増加しています。WHOによると、CVDによる死亡者の約80.0%は、アフリカ、ラテンアメリカ、アジア太平洋などの低中所得者層地域で発生しているとのことです。北米では、心筋梗塞の死亡率は、薬剤溶出ステント、経皮的冠動脈形成術の採用拡大、主要な有害心血管疾患の一次および二次予防のための根拠に基づく薬剤など、いくつかの要因によって継続的に低下しています。
予測期間中、北米が支配的な地域となっています。
予測期間中、北米市場は世界のテレメトリー式ECG装置市場において最大のシェアを占め、リードしています。心血管疾患は、米国における死亡の主な原因であり、急性期病院の病床日数と医師の診察の主な原因となっています。米国疾病管理予防センター(CDC)によると、米国では毎年約61万人の死亡者が心血管疾患によって登録されており、これは死亡者のほぼ4人に1人を占めています。したがって、米国では心電図遠隔測定装置の需要がかなり正確に高く、これが米国を中心とした同地域の市場成長の原動力となっています。
さらに、アジア太平洋地域は予測期間中、世界的に最も高いCAGRで成長すると予想されています。この成長は、病院、コンピュータ化、インフラに関する政府の取り組みが活発化していることに起因しています。インド、中国、日本、オーストラリアなどのアジア太平洋地域では、既存の医療インフラがまだ発展途上にあります。発展途上地域における新しいテレメトリー式ECG装置の開発には、大きな可能性があります。世界のCVDの負担の約半分は、アジア太平洋地域が担っています。したがって、患者数が多いことから、テレメトリー式ECG装置市場の差し迫ったニーズがあることがわかります。
心電図テレメトリ装置市場は、少数の企業によって支配されています。市場成長の鍵を握るのは、Aerotel Medical Systems Ltd.、BioTelemetry Inc.、GEヘルスケア、Medtronic Plc、iRhythm Technologies Inc.、日本光電工業、フィリップスヘルスケア、Medicalgorithmics SAなどの企業です。主要企業は、製品の発売、買収、提携など、いくつかの成長戦略を実行しており、これが世界のテレメトリー式ECG装置市場を押し上げると推定されます。2022年3月、GEヘルスケアはHIMSSでAliveCorとの提携を発表し、新しいデジタルプラットフォームを立ち上げることを発表しました。Orlando Global Health Conference &Exhibitionで、2つの大きな発表を行っています。最初の発表は、AIを活用したデジタルヘルスプラットフォームの開発について。そしてもう1つの発表は、カリフォルニア州マウンテンビューに本社を置くAliveCor社との提携についてで、この提携により、医療機器メーカーの心電計で計測した心電図が、GEヘルスケアのMUSE Cardiac Management Systemに直接配信されることになります。2022年4月、GEヘルスケアとメドトロニックは、拡大する外来診療のニーズに対応するための協業を発表しました。この提携により、顧客は幅広い製品ポートフォリオ、財務ソリューション、卓越したサービスを利用できるようになりました。
COVID-19の影響。テレメトリー式ECG装置の世界市場にネガティブな影響を与えます。
COVID-19の大流行が世界のいくつかの地域を襲っているため、世界のテレメトリー式ECG装置市場で事業を展開している企業は、自由に使える良い見通しを持っています。これらのベンダーは、テレメトリー式ECG装置の需要拡大に対応するため、製造ペースを加速させることが予想されます。COVID-19を監視するために使用される新しい技術への投資は、最近の回で増加しています。これは、世界のテレメトリー式ECG装置市場で事業を行っている企業に進歩の大きな遊び場を提供しています。さらに、テレメトリー式ECG装置市場の大手企業は、COVID-19患者の基本を監視するためのカスタムメイドの装置の開発に注力しています。
ECG telemetry devices market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8 % during the forecast period (2022-2029).
ECG device monitors and records the electrical movement of the heart. It detects and gathers electrical impulses generated by the polarization and depolarization of cardiac tissue and translates them into a waveform. It helps physicians or cardiologists diagnose cardiac abnormalities and the size and position of chambers. This technique detects cardiac abnormalities and analyzes the effects of drugs or devices used to regulate the heart. The ECG telemetry device can detect complex dysrhythmias and myocardial ischemia. The ECG telemetry devices market is driving due to the growing government interventions to reform the healthcare sector. Moreover, technological advances and increasing government interventions to render quality medical devices at affordable prices for miniature and telemetry devices have grown significantly in the past couple of years.
Market Dynamics: Home monitoring devices lead the market's growth.
Homecare monitoring devices' demand increases, reducing the cost and time taken in hospitals for heart checkups. For life-threatening diseases, such as cardiovascular disorders, regular checkup of the heart is crucial, and it is made easy by homecare monitoring devices. Hence, these devices are helping the ECG telemetry devices market to grow.
Also, the Increasing incidence and prevalence of cardiovascular diseases drive market growth. Over the past two decades, fatalities due to cardiovascular disease and other heart diseases have been declining in high-income countries; however, they have been rising at an alarming rate in lower and middle-income countries. Around 80.0% of the mortalities caused due to CVD occur in low-middle income group regions, such as Africa, Latin America, and Asia-Pacific, as per the WHO. In North America, myocardial infarction fatality is continuously decreasing due to several factors, such as drug-eluting stents, increasing adoption of percutaneous coronary angioplasty, and evidence-based medications for primary and secondary prevention of major adverse cardiovascular diseases.
Market Segmentation: Event monitoring and MCT (Mobile Cardiac Telemetry) segment accounted for the highest share in global ECG telemetry devices market.
The event monitoring and MCT (Mobile Cardiac Telemetry) segment are anticipated to dominate the market with the largest value share. Mobile cardiac telemetry is the most modern of the monitoring options. MCT devices are small portable monitors that automatically send data when a cardiac anomaly is detected. It is superior to other forms of ambulatory cardiac monitoring (Holter or Event Monitoring); therefore, its demand is expected to rise in the ECG telemetry device market during the forecast period.
By application, the ECG telemetry devices market is classified into arrhythmia, myocardial ischemia and infarction, pacemaker monitoring, and others. In terms of application, the arrhythmia segment is expected to dominate the global ECG telemetry devices market during the forecast period. In arrhythmia, the heart rhythm functions abnormally, wherein the electrical impulses either occur too fast or too slow, leading to the reduced proficiency of the heart to pump blood. There are various devices used in arrhythmias diagnosis. The ECG telemetry devices are one of the most efficient tools to detect arrhythmias. According to a World Health organization estimation data, the aged population above 60 years and over increased in 2020. By 2050, the aged population above 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As this population is more prone to cardiovascular diseases such as arrhythmias, the demand for ECG telemetry devices to diagnose arrhythmia is expected to impact the market positively.
Geographical Penetration: North America is the dominating region during the forecast period.
During the forecast period, the North American market leads with the largest share in the global ECG telemetry devices market. Cardiovascular diseases are the primary cause of mortality in the U.S. and the major cause of acute hospital bed days and physician visits. According to the Centers for Disease Control and Prevention (CDC), about 610,000 mortalities are registered due to cardiovascular diseases in the U.S. every year, which accounts for almost one in every four fatalities. Therefore, the demand for ECG telemetry devices is considerably accurately high in the U.S., which drives the market growth in the region, especially in the U.S.
Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally during the forecast period. This growth is due to the increased government initiatives on hospitals, computerization, and infrastructure. The existing healthcare infrastructure in the Asia-Pacific countries such as India, China, Japan, and Australia is still in progress. Significant prospects exist for developing novel ECG telemetric devices in developing regions. Approximately half of the burden of the world of CVD is carried by the Asia-Pacific region. Therefore, the large patient population indicates an imminent need for the ECG telemetry device market.
The ECG telemetry devices market is dominated by a few companies. Key players in the market's growth include Aerotel Medical Systems Ltd., BioTelemetry Inc., GE Healthcare, Medtronic Plc, iRhythm Technologies Inc., Nihon Kohden Corporation, Philips Healthcare, and Medicalgorithmics SA, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global ECG telemetry devices market. In March 2022, GE Healthcare announced a partnership with AliveCor to launch a new digital platform at HIMSS. The company made two major announcements at the Orlando Global Health Conference & Exhibition. The company's first announcement is the development of an AI-enabled digital health platform. And another announcement is about a partnership with Mountain View, California-based AliveCor, through which electrocardiogram readings taken on the medical device company's EKG device will be delivered directly into GE Healthcare's MUSE Cardiac Management System. In April 2022, GE Healthcare and Medtronic Announced a Collaboration to Meet the Growing Need for Outpatient Care. Under this collaboration, customers accessed extensive product portfolios, financial solutions, and exceptional service.
COVID-19 Impact: Negative impact on the global ECG Telemetry Devices market.
The companies operating in the global ECG telemetry devices market have a good prospect at their disposal as the COVID-19 pandemic grips several parts worldwide. These vendors are expected to accelerate their manufacturing pace to meet the expanding demand for ECG telemetry devices. Investments in novel technologies used to monitor COVID-19 have increased in recent times. It has offered a large playfield of advancement for the companies operating in the global ECG telemetry devices market. Furthermore, the ECG telemetry devices market's leading players focus on developing custom-made devices to monitor the fundamentals of COVID-19 patients.